FMP
Franklin Genomic Advancements ETF
HELX
AMEX
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
31.55 USD
-0.0666 (-0.211%)
About
ceo
N/A
sector
Financial Services
industry
Asset Management
website
N/A
exchange
AMEX
Description
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
CIK
0001655589
ISIN
US35473P5200
CUSIP
35473P520
Address
N/A
Phone
NA
Country
US
Employee
N/A
IPO Date
Feb 27, 2020
HELX Financial Summary
ISIN
US35473P5200
Exchange
AMEX
Beta
1.11
Market Cap
9.7M
52-Week
25.26-33.976
Volume Avg.
2.28k
Price
31.55
Country
US
Management Assets
-
Total Holdings
-
NAV
-
NAV Currency
-
Historical Prices
We are unable to load the chart at this time.
Sector Weightings
We are unable to load the chart at this time.
Country Weightings
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest HELX News
It looks like there's no news available.
